443PPhase III trial of afatinib vs erlotinib in patients (pts) with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes
Park, K., Li, W., Zhou, C., Felip, E., Cobo, M., Goss, G.D., Soria, J.-C., Syrigos, K., Krämer, N., Chand, V.K., Solca, F., Lu, S.Том:
26
Мова:
english
Журнал:
Annals of Oncology
DOI:
10.1093/annonc/mdv532.27
Date:
December, 2015
Файл:
PDF, 41 KB
english, 2015